Aastrom

Developing autologous stem cell products for use in regenerative medicine
(1989)
Location:
Ann Arbor, MI
Management:
Timothy M. Mayleben, CEO
UM Inventor(s):
Bernhard O. Palsson
Funding parties:
EDF Ventures
IPO:
1997 [NASDAQ:ASTM]
Developing autologous stem cell products for use in regenerative medicine
(1989)
Location:
Ann Arbor, MI
Management:
Timothy M. Mayleben, CEO
UM Inventor(s):
Bernhard O. Palsson
Funding parties:
EDF Ventures
IPO:
1997 [NASDAQ:ASTM]